{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn) is a major constituent of Lewy bodies in Parkinson's disease (PD). The A30P mutation is associated with autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to α-synuclein's role in Lewy body formation in PD and the association of the A30P mutation with familial PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study developed an in vitro assay to characterise the factor(s) involved in α-syn's binding to synaptic membranes, which is relevant to the pathogenesis of PD.",
          "judgment": "Yes",
          "reasoning": "The assay class used effectively models the disease pathogenesis by focusing on α-synuclein's interaction with synaptic membranes, a key aspect of PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both wild-type and PD-linked mutant α-synuclein in the assay, providing a direct comparison and validation of the assay's specificity and applicability to the disease mechanism."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "Statistical analyses were performed using One-Way ANOVA and Bonferroni's multiple comparison test, indicating a significant effect of cytosol on α-syn binding.",
            "judgment": "Yes",
            "reasoning": "The paper provides robust statistical evidence supporting the functional impact of the A30P mutation on α-synuclein's binding to synaptic membranes."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While the paper provides statistical significance, it does not directly calculate OddsPath for the functional data."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "N/A",
            "reasoning": "Not applicable as OddsPath was not calculated in the paper."
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A30P mutation in α-synuclein showed a significantly reduced binding to synaptic membranes compared to wild-type and A53T α-synuclein, which was partially rescued by the presence of cytosolic factors. This suggests a functional impact of the A30P mutation that is consistent with its pathogenic role in PD."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Alpha-Synuclein (α-syn) is a major constituent of Lewy bodies in Parkinson's disease (PD). The A53T mutation is associated with autosomal dominant forms of familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to α-synuclein's role in Lewy body formation in PD and the association of the A53T mutation with familial PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study developed an in vitro assay to characterise the factor(s) involved in α-syn's binding to synaptic membranes, which is relevant to the pathogenesis of PD.",
          "judgment": "Yes",
          "reasoning": "The assay class used effectively models the disease pathogenesis by focusing on α-synuclein's interaction with synaptic membranes, a key aspect of PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both wild-type and PD-linked mutant α-synuclein in the assay, providing a direct comparison and validation of the assay's specificity and applicability to the disease mechanism."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "Statistical analyses were performed using One-Way ANOVA and Bonferroni's multiple comparison test, indicating a significant effect of cytosol on α-syn binding.",
            "judgment": "Yes",
            "reasoning": "The paper provides robust statistical evidence supporting the functional impact of the A53T mutation on α-synuclein's binding to synaptic membranes."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While the paper provides statistical significance, it does not directly calculate OddsPath for the functional data."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "N/A",
            "reasoning": "Not applicable as OddsPath was not calculated in the paper."
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T mutation in α-synuclein showed a significant binding to synaptic membranes, which was enhanced by the presence of cytosolic factors. This suggests a functional impact of the A53T mutation that is consistent with its pathogenic role in PD."
    }
  ]
}